ICU Medical (ICUI) Tops Q2 EPS Views; Boosts FY15 Outlook

ICU Medical (NASDAQ: ICUI) reported Q2 EPS of $0.97, $0.28 better than the analyst estimate of $0.69. Revenue for the quarter came in at $83.8 million versus the consensus estimate of $78.89 million.

ICU Medical sees FY2015 EPS of $2.63-$2.83, versus prior guidance of $2.15-$2.25. ICU Medical sees FY2015 revenue of $325-330 million, versus prior guidance of $312-317 million.

For earnings history and earnings-related data on ICU Medical (ICUI) click here.

You May Also Be Interested In

• Mizuho says ignore Apple noise, flags key catalyst for Micron and memory in H2
• Jefferies Assumes Radico Khaitan Ltd (RDCK:IN) at Buy
• Palantir surges 4% on Nvidia sovereign AI pact as software beats semis